loadpatents
name:-0.069796085357666
name:-0.02527379989624
name:-0.0055959224700928
Buschmann; Helmut Heinrich Patent Filings

Buschmann; Helmut Heinrich

Patent Applications and Registrations

Patent applications and USPTO patent grants for Buschmann; Helmut Heinrich.The latest application filed is for "use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy".

Company Profile
5.25.53
  • Buschmann; Helmut Heinrich - Barcelona ES
  • BUSCHMANN; HELMUT HEINRICH - SANT JUST DESVERN ES
  • Buschmann; Helmut Heinrich - Aachen Wallheim
  • Buschmann; Helmut Heinrich - Aachen DE
  • Buschmann; Helmut Heinrich - Aachen Walheim
  • BUSCHMANN; Helmut Heinrich - Walheim DE
  • Buschmann; Helmut-Heinrich - Esplugues de Llobregat ES
  • Buschmann; Helmut Heinrich - San Just Desvern-Barcelona ES
  • Buschmann; Helmut-Heinrich - Esplugues de LiobregatBarcelona
  • Buschmann; Helmut-Heinrich - Esplugues de Llobregat Barcelona ES
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
Grant 11,419,873 - Buschmann , et al. August 23, 2
2022-08-23
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20210252004 - Buschmann; Helmut Heinrich ;   et al.
2021-08-19
Process For The Preparation Of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
App 20210130282 - HELL; WOLFGANG ;   et al.
2021-05-06
Process For The Preparation Of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
App 20200299225 - HELL; WOLFGANG ;   et al.
2020-09-24
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
Grant 10,624,896 - Buschmann , et al.
2020-04-21
Process For The Preparation Of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
App 20190263747 - HELL; WOLFGANG ;   et al.
2019-08-29
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20190160074 - Buschmann; Helmut Heinrich ;   et al.
2019-05-30
1-aryl-3-aminoalkoxy Pyrazoles As Sigma Ligands Enhancing Analgesic Effect Of Opioids And Attenuating The Dependency Thereof
App 20190010128 - Buschmann; Helmut Heinrich ;   et al.
2019-01-10
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
Grant 10,149,852 - Buschmann , et al. Dec
2018-12-11
1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
Grant 9,914,705 - Buschmann , et al. March 13, 2
2018-03-13
Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
Grant 9,850,198 - Buschmann , et al. December 26, 2
2017-12-26
Process For The Preparation Of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
App 20170217875 - HELL; Wolfgang ;   et al.
2017-08-03
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20170000797 - Buschmann; Helmut Heinrich ;   et al.
2017-01-05
Process for Preparing Substituted 3-(1-amino-2-methylpentane-3-yl)phenyl Compounds
App 20160257640 - BUSCHMANN; Helmut Heinrich ;   et al.
2016-09-08
Process For The Preparation Of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
App 20160221928 - HELL; Wolfgang ;   et al.
2016-08-04
Sigma Ligands For the Prevention or Treatment of Pain Induced by Chemotherapy
App 20160220575 - Baeyens-Cabrera; Jose Manuel ;   et al.
2016-08-04
Sigma Ligands For the Prevention or Treatment of Pain Induced by Chemotherapy
App 20160199380 - Baeyens-Cabrera; Jose Manuel ;   et al.
2016-07-14
Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
Grant 9,388,119 - Buschmann , et al. July 12, 2
2016-07-12
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20150283140 - Buschmann; Helmut Heinrich ;   et al.
2015-10-08
Co-crystals of duloxetine and cox-inhibitors for the treatment of pain
Grant 9,084,774 - Buschmann , et al. July 21, 2
2015-07-21
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
Grant 9,018,222 - Buschmann , et al. April 28, 2
2015-04-28
1-aryl-3-aminoalkoxy Pyrazoles As Sigma Ligands Enhancing Analgesic Effect Of Opioids And Attenuating The Dependency Thereof
App 20150018354 - Buschmann; Helmut Heinrich ;   et al.
2015-01-15
Process For The Preparation Of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
App 20140378706 - HELL; Wolfgang ;   et al.
2014-12-25
CO-CRYSTALS OF TRAMADOL AND NSAIDs
App 20140350110 - BUSCHMANN; Helmut Heinrich ;   et al.
2014-11-27
1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
Grant 8,877,753 - Buschmann , et al. November 4, 2
2014-11-04
Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropy1)-phenol
Grant 8,877,974 - Hell , et al. November 4, 2
2014-11-04
Process for preparing substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
Grant 8,669,399 - Buschmann , et al. March 11, 2
2014-03-11
Co-crystals Of Duloxetine And Cox-inhibitors For The Treatment Of Pain
App 20140024697 - Buschmann; Helmut Heinrich ;   et al.
2014-01-23
Process for Preparing Substituted 3-(1-amino-2-methylpentane-3-yl)phenyl Compounds
App 20130338399 - BUSCHMANN; Helmut Heinrich ;   et al.
2013-12-19
Co-crystals of duloxetine and COX-INHIBITORs for the treatment of pain
Grant 8,501,802 - Buschmann , et al. August 6, 2
2013-08-06
Sigma Ligands For The Prevention Or Treatment Of Pain Induced By Chemotherapy
App 20120141606 - Baeyens-Cabrera; Jose Manuel ;   et al.
2012-06-07
Active Substance Combination Comprising A Compound With Npy Receptor Affinity And A Compound With 5-ht6 Receptor Affinity
App 20120128768 - Torrens Jover; Antoni ;   et al.
2012-05-24
Salts of Tramadol and Naproxen and their crystal forms in the treatment of pain
Grant 8,168,679 - Buschmann , et al. May 1, 2
2012-05-01
Process for Preparing Substituted 3-(1-amino-2-methylpentane-3-yl)phenyl Compounds
App 20110306793 - BUSCHMANN; Helmut Heinrich ;   et al.
2011-12-15
Process for the Preparation of Substituted 1-aminomethyl-2-phenyl-cyclohexane Compounds
App 20110295038 - HOLENZ; Joerg ;   et al.
2011-12-01
CO-CRYSTALS OF TRAMADOL AND NSAIDs
App 20110257134 - Buschmann; Helmut Heinrich ;   et al.
2011-10-20
Salts Of Tramadol And Ibuprofen And Their Crystal Form In The Treatment Of Pain
App 20110178174 - Buschmann; Helmut Heinrich ;   et al.
2011-07-21
2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine Derivatives And Related Compounds As Neuropeptide Y5 (npy5) Ligands For The Treatment Of Obesity
App 20110172270 - Torrens; Antoni Jover ;   et al.
2011-07-14
Co-crystals Of Duloxetine And Cox-inhibitors For The Treatment Of Pain
App 20110160273 - Buschmann; Helmut Heinrich ;   et al.
2011-06-30
1-aryl-3-aminoalkoxy Pyrazoles As Sigma Ligands Enhancing Analgesic Effect Of Opioids And Attenuating The Dependency Thereof
App 20110112095 - Buschmann; Helmut Heinrich ;   et al.
2011-05-12
Salts Of Memantine And Cox-inhibitors And Their Crystal Form In The Treatment Of Pain
App 20110105443 - Buschmann; Helmut Heinrich ;   et al.
2011-05-05
Crystalline Modifications of 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol
App 20110060053 - Gruss; Michael ;   et al.
2011-03-10
2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide Y5 (NPY5) ligands for the treatment of obesity
Grant 7,888,510 - Torrens , et al. February 15, 2
2011-02-15
Rhodium-phosphorus Complexes And Their Use In Ring Opening Reactions
App 20110004005 - Heller; Detfleff ;   et al.
2011-01-06
2-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - Acetamine Derivatives And Related Compounds As Neuropeptide Y5 (npy5) Ligands For The Treatment Of Obesity
App 20100280072 - TORRENS JOVER; Antoni ;   et al.
2010-11-04
Salts Of Tramadol And Naproxen And Their Crystal Forms In The Treatment Of Pain
App 20100227927 - Buschmann; Helmut Heinrich ;   et al.
2010-09-09
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20100215771 - Buschmann; Helmut Heinrich ;   et al.
2010-08-26
Process for producing (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-d- iol
Grant 7,763,754 - Buschmann , et al. July 27, 2
2010-07-27
Combination Of A Cholinesterase Inhibitor And A Compound With 5-ht6 Receptor Affinity
App 20100120747 - Codony-Soler; Xavier ;   et al.
2010-05-13
Process for the Preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol
App 20100099916 - Hell; Wolfgang ;   et al.
2010-04-22
Combination of NMDA-Receptor Ligand and a Compound With 5-HT6 Receptor Affinity
App 20100074955 - Buschmann; Helmut Heinrich ;   et al.
2010-03-25
Separation of stereoisomeric N,N-dialkylamino-2alkyl-3-hydroxy-3-phenylalkanes
Grant 7,649,114 - Buschmann , et al. January 19, 2
2010-01-19
Process for Producing (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-d- iol
App 20090253936 - BUSCHMANN; Helmut Heinrich ;   et al.
2009-10-08
Process For Obtaining Enantiomers Of Duloxetine Precursors
App 20090247771 - Buschmann; Helmut Heinrich ;   et al.
2009-10-01
Substituted Tetrahydroisoquinoline Compound, Their Preparation And Use In Medicaments
App 20090209528 - Mas Prio; Josep ;   et al.
2009-08-20
Tetrodotoxin And Its Derivatives For The Treatment Of Central-Nervously Derived Neuropathic Pain
App 20090143415 - Buschmann; Helmut Heinrich ;   et al.
2009-06-04
Separation of Stereoisomeric N,N-Dialkylamino-2Alkyl-3-Hydroxy-3-Phenylalkanes
App 20080269524 - Buschmann; Helmut Heinrich ;   et al.
2008-10-30
2-'4-(Hydroxymethyl-phenylamino)-piperidine-1-yl!-n-(9h-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
App 20070105853 - Torrens Jover; Antoni ;   et al.
2007-05-10
Active substance combination comprising a carbinol combined to at least an NSAID
App 20070088024 - Buschmann; Helmut Heinrich ;   et al.
2007-04-19
Active substance combination
App 20070082893 - Buschmann; Helmut Heinrich ;   et al.
2007-04-12
Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
App 20070059364 - Torrens Jover; Antoni ;   et al.
2007-03-15
Piperidine-2,6-diones heterocyclically substituted in the 3-position
Grant 7,183,274 - Buschmann , et al. February 27, 2
2007-02-27
Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
App 20070032471 - Torrens Jover; Antoni ;   et al.
2007-02-08
Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
App 20070009597 - Torrens Jover; Antoni ;   et al.
2007-01-11
Active substance combination
App 20050222135 - Buschmann, Helmut Heinrich ;   et al.
2005-10-06
Active substance combination
App 20050222136 - Buschmann, Helmut Heinrich ;   et al.
2005-10-06
Piperidine-2,6-diones heterocyclically substituted in the 3-position
App 20050020581 - Buschmann, Helmut Heinrich ;   et al.
2005-01-27
6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
Grant RE37,355 - Buschmann , et al. September 4, 2
2001-09-04
6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
Grant 5,733,936 - Buschmann , et al. March 31, 1
1998-03-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed